The Georgia Drug Utilization Review Board (DURB) was established under the authority of Section 1903(3) A of the Omnibus Budget Reconciliation Act of 1990 (OBRA). The Board promotes patient safety through an increased review and awareness of outpatient prescribed drugs. It recommends medical criteria, standards and educational intervention methods used in the DUR program. It also advises DCH about products considered to be the most clinically effective for members of the Department's plans: Medicaid and PeachCare for Kids®. The Board reviews drug therapy, drug studies and utilization information, thus enabling the Department to identify the most cost-effective policies for its members.
The board, appointed by the DCH Commissioner, is composed of:
- Members of the academic community
- A consumer advocate
SXC Health Solutions, the department's pharmacy benefits manager, hosts the Manufacturers' Forum, provides clinical information for the Board's review and makes the clinical presentations at the DURB meetings.